These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36611033)

  • 1. Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients.
    Kargutkar N; Sawant-Mulay M; Hariharan P; Chandrakala S; Nadkarni A
    Sci Rep; 2023 Jan; 13(1):369. PubMed ID: 36611033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.
    Pule GD; Mowla S; Novitzky N; Wiysonge CS; Wonkam A
    Expert Rev Hematol; 2015 Oct; 8(5):669-79. PubMed ID: 26327494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia.
    Walker AL; Steward S; Howard TA; Mortier N; Smeltzer M; Wang YD; Ware RE
    Blood; 2011 Nov; 118(20):5664-70. PubMed ID: 21921042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease.
    Pule GD; Mowla S; Novitzky N; Wonkam A
    Clin Transl Med; 2016 Mar; 5(1):15. PubMed ID: 27056246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
    Pecoraro A; Rigano P; Troia A; Calzolari R; Scazzone C; Maggio A; Steinberg MH; Di Marzo R
    Eur J Haematol; 2014 Jan; 92(1):66-72. PubMed ID: 24112139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.
    Chou YC; Chen RL; Lai ZS; Song JS; Chao YS; Shen CK
    Mol Cell Biol; 2015 Jul; 35(14):2541-53. PubMed ID: 25986606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness.
    Zhu X; Hu T; Ho MH; Wang Y; Yu M; Patel N; Pi W; Choi JH; Xu H; Ganapathy V; Kutlar F; Kutlar A; Tuan D
    Haematologica; 2017 Dec; 102(12):1995-2004. PubMed ID: 28971909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
    Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia.
    Cyrus C; Vatte C; Al-Nafie A; Chathoth S; Akhtar MS; Darwish M; Almohazey D; AlDubayan SH; Steinberg MH; Al-Ali A
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295630
    [No Abstract]   [Full Text] [Related]  

  • 10. Determinants of fetal hemoglobin response to hydroxyurea.
    Steinberg MH
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):8-14. PubMed ID: 9317196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea-inducible SAR1 gene acts through the Giα/JNK/Jun pathway to regulate γ-globin expression.
    Zhu J; Chin K; Aerbajinai W; Kumkhaek C; Li H; Rodgers GP
    Blood; 2014 Aug; 124(7):1146-56. PubMed ID: 24914133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and α-thalassemia.
    Ballas SK; Connes P;
    Eur J Haematol; 2018 Dec; 101(6):798-803. PubMed ID: 30204261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging science of hydroxyurea therapy for pediatric sickle cell disease.
    Green NS; Barral S
    Pediatr Res; 2014 Jan; 75(1-2):196-204. PubMed ID: 24252885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease.
    Li B; Zhu X; Ward CM; Starlard-Davenport A; Takezaki M; Berry A; Ward A; Wilder C; Neunert C; Kutlar A; Pace BS
    Exp Hematol; 2019 Feb; 70():85-96.e5. PubMed ID: 30412705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects.
    Junker LH; Li B; Zhu X; Koti S; Cerbone RE; Hendrick CL; Sangerman J; Perrine S; Pace BS
    Blood Cells Mol Dis; 2022 Mar; 93():102626. PubMed ID: 34856533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bach1 inhibitor HPP-D mediates γ-globin gene activation in sickle erythroid progenitors.
    Palani CD; Zhu X; Alagar M; Attucks OC; Pace BS
    Blood Cells Mol Dis; 2024 Jan; 104():102792. PubMed ID: 37633023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea.
    Chondrou V; Stavrou EF; Markopoulos G; Kouraklis-Symeonidis A; Fotopoulos V; Symeonidis A; Vlachaki E; Chalkia P; Patrinos GP; Papachatzopoulou A; Sgourou A
    Hum Genomics; 2018 Oct; 12(1):45. PubMed ID: 30285874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.
    Allard P; Alhaj N; Lobitz S; Cario H; Jarisch A; Grosse R; Oevermann L; Hakimeh D; Tagliaferri L; Kohne E; Kopp-Schneider A; Kulozik AE; Kunz JB
    Haematologica; 2022 Jul; 107(7):1577-1588. PubMed ID: 34706496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
    Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
    Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.
    Bernaudin F; Arnaud C; Kamdem A; Hau I; Lelong F; Epaud R; Pondarré C; Pissard S
    Blood Adv; 2018 Mar; 2(6):626-637. PubMed ID: 29555644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.